Lysosomal enzymes in human peripheral blood mononuclear cells and granulocytes

Clinical Chemistry

Volumn 51, Issue 3, 2005, Pages 646-649

  Isman, Ferruh ^a,e   Palomaki, Glenn E ^b   Natowicz, Marvin R ^a,c,d,f  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b FOUNDATION FOR BLOOD RESEARCH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Taksim Teaching Hospital   (Turkey)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCOSIDASE; BETA MANNOSIDASE; BETA N ACETYLHEXOSAMINIDASE A; BETA N ACETYLHEXOSAMINIDASE B; CELL PROTEIN; CEREBROSIDE SULFATASE; LEVO IDURONIDASE; LYSOSOME ENZYME;

ARTICLE; BONE MARROW TRANSPLANTATION; CORD BLOOD STEM CELL TRANSPLANTATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME REPLACEMENT; GAUCHER DISEASE; GRANULOCYTE; HETEROZYGOSITY; HUMAN; HURLER SYNDROME; LYSOSOME STORAGE DISEASE; MACROMOLECULE; METACHROMATIC LEUKODYSTROPHY; PATIENT MONITORING; PERIPHERAL BLOOD MONONUCLEAR CELL; SCHEIE SYNDROME; TAY SACHS DISEASE;

ADULT; GRANULOCYTES; HUMANS; LEUKOCYTES, MONONUCLEAR; LYSOSOMES;

EID: 14544293933     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.045930     Document Type: Article

References (27)

1. Gieselmann V. Lysosomal storage diseases. Biochim Biophys Acta 1995;1270:103-36.
2. Winchester B, Vellodi A, Young E. The molecular basis of lysosomal storage diseases and their treatment. Biochem Soc Trans 2000;28:150-4.
3. Weibel TD, Brady RO. Systematic approach to the diagnosis of lysosomal storage disorders. MRDD Res Rev 2001;7:190-9.
4. Wenger DA, Coppola S, Liu S-L. Lysosomal storage disorders: diagnostic dilemmas and prospects for therapy. Genet Med 2002;4:412-9.
5. Rome LH, Weissmann B, Neufeld EF. Direct demonstration of binding of a lysosomal enzyme, α-L-iduronidase, to receptors on cultured fibroblasts. Proc Natl Acad Sci U S A 1979;76:2331-4.
6. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
7. Prence EM, Natowicz MR, Zalewski I. Unusual thermolability properties of leukocyte β-hexosaminidase: implications in screening for carriers of Tay-Sachs disease. Clin Chem 1993;39:1811-4.
8. Raghavan SS, Topol J, Kolodny EH. Leukocyte β-glucosidase in homozygotes and heterozygotes for Gaucher disease. Am J Hum Genet 1980;32:158-73.
9. Panday RS, van Diggelen OP, Kleijer WJ, Niermeijer MF. β-Mannosidase in human leukocytes and fibroblasts. J Inherit Metab Dis 1984;7:155-6.
10. Lee-Vaupel M, Conzelmann E. A simple chromogenic assay for arylsulfatase A. Clin Chim Acta 1987;164:171-80.
11. Gravel RA, Kaback MM, Proia RL, Sandhoff K, Suzuki K, Suzuki K. The GM2 gangliosidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001:3827-76.
12. Natowicz MR, Prence EM. Heterozygote screening for Tay-Sachs disease: past successes and future challenges. Curr Opin Pediatr 1996;8:625-9.
13. Prence EM, Zalewski I, Natowicz MR. Unusual thermolability properties of β-hexosaminidase: studies of enzyme from cultured cells and clinical implications. Am J Med Genet 1996;65:320-4.
14. Beutler E, Kuhl W, Matsumoto F, Pangalis G. Acid hydrolases in leukocytes and platelets of normal subjects and in patients with Gaucher's and Fabry's disease. J Exp Med 1976;143:975-80.
15. Nakagawa S, Kumin S, Fox D, Nitowsky HM. Human hexosaminidase isozymes. III. Distribution and activity of isozymes in peripheral blood leukocytes and platelets. J Lab Clin Med 1978;91:922-8.
16. Tanaka T. The different composition of eight lysosomal enzymes in human peripheral lymphocytes and granulocytes. Hiroshima J Med Sci 1978;27:253-9.
17. Casal JA, Chabas A, Tutor JC. Thermodynamic determination of β-hexosaminidase isoenzymes in mononuclear and polymorphonuclear leukocyte populations. Am J Med Genet 2003;116A:229-33.
18. Ellis RB, Rapson NT, Patrick AD, Greaves MF. Expression of hexosaminidase isoenzymes in childhood leukemia. N Engl J Med 1978;298:476-80.
19. Beutler E, Grabowski GA. Gaucher disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001:3635-68.
20. Nakagawa S, Kumin S, Nitowsky HM. Studies on the activities and properties of lysosomal hydrolases in fractionated populations of human peripheral blood cells. Clin Chim Acta 1980;101:33-44.
21. Von Figura K, Gieselmann V, Jaeken J. Metachromatic leukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001:3695-724.
22. Krivit W, Aubourg P, Shapiro E, Peters C. Bone marrow transplantation for globoid leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy and Hurler syndrome. Curr Opin Hematol 1999;6:377-82.
23. Georgopoulos DE, Manowitz P. Arylsulfatase A activity and electrophoretic banding patterns from isolated human blood fractions. Biochem Genet 1982;20:907-18.
24. Shah SN, Johnson RC, Minn K, Schoenfeld F. Arylsulfatase A and β-galactosidase activities in leukocytes and lymphocytes from normal and psychiatric subjects. Mol Chem Neuropathol 1995;24:43-52.
25. Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001:3421-52.
26. Thomas GJ. Disorders of glycoprotein degradation: α-mannosidosis, β-mannosidosis, fucosidosis, and sialidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001:3507-33.
27. Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P, et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 2004;350:1960-9.